All In MedTech

Device Trial Radar · NCT03949777

Validation of Aer-O-Scope Colonoscope System Cecal Intubation

Last checked: Nov 20, 2026Latest source record: Nov 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

79

Actual

Start

Jan 6, 2020

Primary completion

Aug 10, 2021

Study completion Nov 14, 2021

Sponsor

Lead sponsor
GI View Ltd.Not on our public-company list
Sponsor type
Industry
First posted
May 14, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated device
No
Who can join
All sexes, from 45 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

61 subjects (male or female) between the ages of 45 and 75 will undergo colonoscopy. The primary outcome is Cecal Intubation

Conditions

  • Colonic Polyp
  • Colonic Neoplasms
  • Colonic Diseases
  • Colon Adenoma
  • Colon Disease
  • Colon Adenocarcinoma
  • Colon Cancer

Interventions

  • Aer-O-Scope ColonoscopyDevice

    resection or biopsy of colonic abnormalities for histopathalogical evaluation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Aer-O-Scope Validation of Cecal IntubationTime frame: 30 minutes

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sourasky Medical Center

    Tel Aviv, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.